First Eagle Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,636
| Closed | -$161K | – | 451 |
|
|
2025
Q3 | $161K | Sell |
1,636
-3,089
| -65% | -$306K | ﹤0.01% | 396 |
|
|
2025
Q2 | $431K | Buy |
4,725
+499
| +12% | +$48.3K | ﹤0.01% | 367 |
|
|
2025
Q1 | $478K | Sell |
4,226
-300
| -7% | -$32.1K | ﹤0.01% | 378 |
|
|
2024
Q4 | $478K | Hold |
4,526
| – | – | ﹤0.01% | 389 |
|
|
2024
Q3 | $489K | Sell |
4,526
-2,060
| -31% | -$225K | ﹤0.01% | 357 |
|
|
2024
Q2 | $715K | Buy |
6,586
+1,820
| +38% | +$215K | ﹤0.01% | 355 |
|
|
2024
Q1 | $629K | Hold |
4,766
| – | – | ﹤0.01% | 364 |
|
|
2023
Q4 | $580K | Hold |
4,766
| – | – | ﹤0.01% | 360 |
|
|
2023
Q3 | $535K | Buy |
4,766
+963
| +25% | +$122K | ﹤0.01% | 360 |
|
|
2023
Q2 | $554K | Buy |
3,803
+1,276
| +50% | +$173K | ﹤0.01% | 343 |
|
|
2023
Q1 | $326K | Buy |
2,527
+2,340
| +1,251% | +$294K | ﹤0.01% | 362 |
|
|
2022
Q4 | $23.8K | Hold |
187
| – | – | ﹤0.01% | 380 |
|
|
2022
Q3 | $20K | Buy |
187
+167
| +835% | +$18.3K | ﹤0.01% | 385 |
|
|
2022
Q2 | $2K | Buy |
+20
| New | +$2.37K | ﹤0.01% | 390 |
|
|
2018
Q1 | – | Sell |
-509
| Closed | -$60K | – | 296 |
|
|
2017
Q4 | $60K | Hold |
509
| – | – | ﹤0.01% | 293 |
|
|
2017
Q3 | $58K | Hold |
509
| – | – | ﹤0.01% | 310 |
|
|
2017
Q2 | $63K | Hold |
509
| – | – | ﹤0.01% | 285 |
|
|
2017
Q1 | $60K | Sell |
509
-390
| -43% | -$44.2K | ﹤0.01% | 277 |
|
|
2016
Q4 | $90K | Hold |
899
| – | – | ﹤0.01% | 270 |
|
|
2016
Q3 | $114K | Hold |
899
| – | – | ﹤0.01% | 285 |
|
|
2016
Q2 | $105K | Hold |
899
| – | – | ﹤0.01% | 297 |
|
|
2016
Q1 | $93K | Hold |
899
| – | – | ﹤0.01% | 286 |
|
|
2015
Q4 | $90K | Hold |
899
| – | – | ﹤0.01% | 274 |
|
|
2015
Q3 | $82K | Hold |
899
| – | – | ﹤0.01% | 272 |
|
|
2015
Q2 | $95K | Hold |
899
| – | – | ﹤0.01% | 268 |
|
|
2015
Q1 | $103K | Hold |
899
| – | – | ﹤0.01% | 278 |
|
|
2014
Q4 | $99K | Hold |
899
| – | – | ﹤0.01% | 286 |
|
|
2014
Q3 | $88K | Sell |
899
-257
| -22% | -$25.3K | ﹤0.01% | 284 |
|
|
2014
Q2 | $117K | Sell |
1,156
-525
| -31% | -$51.2K | ﹤0.01% | 273 |
|
|
2014
Q1 | $154K | Hold |
1,681
| – | – | ﹤0.01% | 310 |
|
|
2013
Q4 | $152K | Hold |
1,681
| – | – | ﹤0.01% | 301 |
|
|
2013
Q3 | $134K | Hold |
1,681
| – | – | ﹤0.01% | 286 |
|
|
2013
Q2 | $122K | Buy |
+1,681
| New | +$126K | ﹤0.01% | 302 |
|
Other funds holding ZBH
First Eagle Investment Management's ZBH Position: Q4 2025 in Review
First Eagle Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 1,636 shares — an estimated $161K sold.
First Eagle Investment Management first reported a position in ZBH in Q2 2013 and held it in 33 quarters. The position peaked at $715K in Q2 2024. 947 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- First Eagle Investment Management reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
- First Eagle Investment Management sold 1,636 Zimmer Biomet shares in Q4 2025, an estimated $161K.
- First Eagle Investment Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 33 quarters.
- First Eagle Investment Management's Zimmer Biomet position peaked at $715K in Q2 2024.
- 947 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on First Eagle Investment Management's 13F filing for Q4 2025, filed 4 Feb 2026.